Welcome back to another episode of Wall Street Unplugged.
As you may know, I’ve been reporting live from the 2018 Consumer Electronics Show this week. And I’ve got some interesting observations to report…
But on this week’s show, we’re going to focus on another major conference investors shouldn’t overlook: the annual J.P. Morgan Healthcare Conference. It’s attended by 400-plus biotech companies and over 10,000 industry professionals.
And today I’ve reached out to my No. 1 healthcare industry analyst, Marc Lichtenfeld, to give us the inside scoop.
Marc is Chief Income Strategist at The Oxford Club. He’s covered the biotech and healthcare sectors for over a decade.
Tune in as Marc talks about promising new drug development and innovation across the healthcare sector… and why he thinks biotech has finally reached an “inflection point.”
Marc also reveals two small-cap biotech companies with untapped potential.
Frank CurzioDownload Transcript